Indication
Eosinophilic Esophagitis (EoE)
3 clinical trials
5 products
Product
BudesonideProduct
DupilumabClinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic EsophagitisStatus: Active (not recruiting), Estimated PCD: 2022-06-02
Product
Matching PlaceboClinical trial
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)Status: Terminated, Estimated PCD: 2022-04-26
Product
AQ280Clinical trial
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose, and Food Effect Evaluation Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of AQ280 in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-07-10
Product
Placebo